Prof. Siddharth Sridhar
Clinical Associate Professor
Department of Microbiology, The University of Hong Kong
biography
Dr. Sridhar is a Clinical Associate Professor at the Department of Microbiology of The University of Hong Kong. He trained as a clinical virologist after obtaining his medical degree from The University of Hong Kong. Dr. Sridhar’s research focuses on hepatitis E virus in immunocompromised hosts with a focus on virus variants circulating in east Asia. In 2018, he discovered that rat hepatitis E virus causes hepatitis in humans and evades detection by conventional hepatitis E diagnostic tests. He has established a surveillance network for rat hepatitis E in China using state-of-art diagnostics, finding that this virus is an important rodent-origin human infectious disease in immunocompromised persons. He has also invented virus-like-particle vaccines and innovative disease models for rat hepatitis E. He has published over 100 articles in leading journals. He has received several awards and accolades for his research including the Heine-Medin Award for young scientists with remarkable research in virology (of which he is the first recipient outside Europe), the Sir Patrick Manson Gold Medal for best MD thesis, the Lo Ying Shek Chi Wai Foundation Award for Young Investigators, and the HKUMed Faculty Clinical Service Excellence Award. He is a Clarivate Highly Cited Researcher (2025).
Title
Rat Hepatitis E: what next?
abstract
The diverse Hepeviridae family of RNA viruses includes several variants that cause hepatitis E in humans. Viruses belonging to the species Rocahepevirus ratti (also known as rat hepatitis E virus), are ubiquitous pathogens of rodents that were previously considered unable to infect humans due to low sequence identity with conventional agents causing hepatitis E. However, in 2018, the first case of rat hepatitis E infection was reported in Hong Kong. Since then, cases have been reported in multiple countries in Asia, North America, and Europe establishing rat hepatitis E as a new zoonosis that evades conventional diagnostic testing. Eight years of systematic public health surveillance in Hong Kong have clarified epidemiological and clinical features of rat hepatitis E, but key questions remain unanswered. Notably, despite being less common than swine hepatitis E, rat hepatitis E virus has become a major cause of chronic hepatitis E in immunocompromised individuals in Hong Kong. This talk will summarize the global experience with rat hepatitis E to date. Molecular epidemiology and approaches to subtyping under the current International Committee on Taxonomy of Viruses (ICTV) framework will be shared. Advanced model systems incorporating rat hepatitis E will be discussed.
